XJPX7090
Market cap8mUSD
Dec 24, Last price
952.00JPY
1D
-5.27%
1Q
-24.32%
IPO
-34.57%
Name
Ligua Inc
Chart & Performance
Profile
Ligua Inc., a consultancy company, engages in the provision of management support services in the healthcare industry. It operates through two segments: Orthopedic Clinic Solutions Business and Financial Services Business. The company offers orthopedic clinic software solutions comprising Ligoo POS & CRM, a patient information management system for osteopathic clinics; and ReceONE is a receipt calculation system used when submitting a medical expenses payment application to a health insurance association. It also provides orthopedic clinic equipment/consumables, such as EMS-indepth-, an electrical muscle stimulation device that exercises muscles by applying electrical stimulation to the body from the outside; Thomson bed, a hydraulic-electric treatment table, designed to treat pain caused by distortion of the pelvis and spine; Inject Energy, a low-frequency treatment device, used to reduce pain and improve muscle atrophy by stimulating the deep parts of the body; Dr.Supporter, a general medical device that uses Integrated Functional Mineral Crystal technology, that promotes blood circulation, recovers from fatigue, relieves muscle fatigue and stiffness, relieves neuralgia, lower back pain, muscle pain, and supports the core; and teaching materials and technical DVDs for treatment methods. In addition, the company educational training consulting services, including training programs and online customer attraction consulting based on the characteristics and guidelines of the orthopedic clinic industry; and medical expenses billing agency services. Further, it is involved in the insurance agency and financial instruments intermediary activities, as well as provision of financial consulting, including mergers and acquisitions mediation, to general business companies. The company was incorporated in 2004 and is headquartered in Osaka, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
Income | |||||
Revenues | 3,430,416 20.89% | 2,837,667 -11.40% | 3,202,949 19.18% | ||
Cost of revenue | 3,325,041 | 3,345,006 | 3,044,237 | ||
Unusual Expense (Income) | |||||
NOPBT | 105,375 | (507,339) | 158,712 | ||
NOPBT Margin | 3.07% | 4.96% | |||
Operating Taxes | 20,655 | (108,902) | 46,458 | ||
Tax Rate | 19.60% | 29.27% | |||
NOPAT | 84,720 | (398,437) | 112,254 | ||
Net income | 104,085 -113.44% | (774,467) -1,169.63% | 72,405 -53.95% | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | 5,102 | (37,240) | 10,575 | ||
BB yield | -0.17% | 1.72% | -0.28% | ||
Debt | |||||
Debt current | 1,627,306 | 1,212,472 | 436,543 | ||
Long-term debt | 764,637 | 1,047,807 | 1,069,646 | ||
Deferred revenue | 18,656 | ||||
Other long-term liabilities | 21,088 | 20,994 | 2 | ||
Net debt | 1,064,548 | 1,027,285 | 74,614 | ||
Cash flow | |||||
Cash from operating activities | 2,830 | (328,222) | 80,065 | ||
CAPEX | (22,578) | (139,444) | (295,651) | ||
Cash from investing activities | 10,783 | (603,709) | (474,611) | ||
Cash from financing activities | 137,185 | 719,850 | (154,133) | ||
FCF | (320,798) | (933,873) | (39,184) | ||
Balance | |||||
Cash | 1,327,394 | 1,172,994 | 1,381,575 | ||
Long term investments | 999 | 60,000 | 50,000 | ||
Excess cash | 1,155,874 | 1,091,111 | 1,271,428 | ||
Stockholders' equity | 164,624 | (13,353) | 760,419 | ||
Invested Capital | 2,853,309 | 2,626,981 | 1,845,488 | ||
ROIC | 3.09% | 5.85% | |||
ROCE | 3.49% | 6.09% | |||
EV | |||||
Common stock shares outstanding | 1,462 | 1,403 | 1,432 | ||
Price | 2,022.00 31.30% | 1,540.00 -41.93% | 2,652.00 -27.64% | ||
Market cap | 2,957,058 36.89% | 2,160,136 -43.13% | 3,798,576 -27.21% | ||
EV | 4,021,606 | 3,187,582 | 3,873,190 | ||
EBITDA | 261,956 | (257,732) | 359,679 | ||
EV/EBITDA | 15.35 | 10.77 | |||
Interest | 21,092 | 16,525 | 10,065 | ||
Interest/NOPBT | 20.02% | 6.34% |